Sangamo Therapeutics Overview
Company Headquarters: California, US
Founded: 1995
Workforce: ~500
Company Working: Sangamo Therapeutics is a clinical-stage biopharmaceutical company which is engaged in the development of new medicines for the treatment of serious genetic diseases. It develops genomic medicines to change the lives of patients with serious diseases. The company is developing a strong, sustainable, differentiated, innovative, and genomic medicine pipeline that helps patients with life-limiting conditions. The company uses proprietary zinc finger genome engineering technology and manufacturing expertise for the development of new medicines. It has a strong business presence in the North America region.
Strategy
Sangamo Therapeutics focuses on developing a diversified product portfolio by the innovation and development of products, thus delivering integrated solutions to large healthcare customers. It also emphasizes collaborations to enhance its market presence in the industry. Its strategy is to use science-based innovation to deliver better patient outcomes. It is also committed to the principle of equal employment opportunity out of moral and legal obligations.
